Belgium· BE-AMP-SAM512186-00

Emtricitabine/Tenofovir Disoproxil Krka 200 mg - 245 mg

A tenofovir disoproxil and emtricitabine product containing emtricitabine, registered in Belgium by KRKA d.d. Novo mesto. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR03

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about emtricitabineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tenofovir disoproxil and emtricitabine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR03 (tenofovir disoproxil and emtricitabine), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search tenofovir disoproxil and emtricitabine products by name

Tenofovir disoproxil and emtricitabine · ATC J05AR03

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Emtricitabine
Manufacturer: KRKA d.d. Novo mesto
Country: Belgium (BE)
ATC code: J05AR03
ATC class: Tenofovir disoproxil and emtricitabine
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 12

5 priced

be_apb
4816138
EUR 365.41
be_apb
5826888
EUR 365.41
be_apb
5812375
EUR 365.41
be_apb
7720212
be_apb
4204459
be_apb
7727969
be_apb
4204467
be_apb
7740764
be_apb
7748874
be_apb
7748882
be_apb
3546702
EUR 365.41
be_apb
3546710
EUR 158.65

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

9 interactions on record for tenofovir disoproxil and emtricitabine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tenofovir disoproxil and emtricitabine against other medicines How interaction checks work

Tenofovir disoproxil and emtricitabine · interactions on record

9 records

9 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Tenofovir disoproxil and emtricitabine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir disoproxil and emtricitabine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys
Iceland · Emtriva
Liechtenstein · Emtriva
Norway · Emtriva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b913fd1e-b470-45a4-b250-f5b25e9ef63f
GET /v1/drugs/b913fd1e-b470-45a4-b250-f5b25e9ef63f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Emtricitabine/Tenofovir Disoproxil Krka 200 mg - 245 mg",
  "name_fr": "Emtricitabine/Tenofovir Disoproxil Krka 200 mg - 245 mg",
  "name_nl": "Emtricitabine/Tenofovir Disoproxil Krka 200 mg - 245 mg",
  "amp_code": "SAM512186-00",
  "strengths": [
    "200.0000",
    "200.0000",
    "300.7000",
    "300.7000",
    "245.0000",
    "245.0000",
    "80.0000"
  ],
  "pack_count": 10,
  "substances": [
    "Emtricitabine",
    "Tenofovir Disoproxil Succinate",
    "Tenofovir Disoproxil",
    "Lactose Monohydrate",
    "Sodium Stearyl Fumarate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tenofovir Disoproxil and Emtricitabine",
  "authorisation_numbers": [
    "EU/1/16/1151/001",
    "EU/1/16/1151/003",
    "EU/1/16/1151/002",
    "EU/1/16/1151/004",
    "EU/1/16/1151/005"
  ]
}

API reference MCP server Plans

See everything about tenofovir disoproxil and emtricitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console